To further determine the mechanism by which flubendazole regulates PCSK9 protein, we performed CETSA using intact Huh7, PLC/PRF/5, and HCC-LY10 cells with flubendazole or control treatment. Here, HSPG2 is linked to hepatocellular carcinoma.